
    
      Insulin glargine has a longer action than compared to NPH insulin, but whether this results
      in improved control when compared to twice-daily NPH insulin is not known when used in
      low-income ethnic minority patients. This study investigates whether insulin glargine may be
      more or less effective and safe than twice-daily NPH insulin in this population.
    
  